CSE Bulletin: Reinstatement - WPD Pharmaceuticals Inc. (WBIO)
- 63
Toronto, Ontario--(Newsfile Corp. - le 20 décembre/December 2024) - Effective immediately, WPD Pharmaceuticals Inc. will be reinstated for trading.
The Company has rectified the situation that gave rise to the suspension.
_________________________________
Avec effet immédiat, WPD Pharmaceuticals Inc. sera réintégrée à la négociation.
La Société a rectifié la situation qui a donné lieu à la suspension.
| Date : | le 20 DEC 2024 |
| Symbol(s)/Symbole(s) : | WBIO |
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: [email protected]
Si vous avez des questions ou si vous avez besoin d'informations supplémentaires, veuillez contacter le service des inscriptions au 416 367-7340 ou par courriel l’adresse: [email protected]
Newsfile Corp. is a press release service for companies of all sizes. With a distribution of over 6,000 media and financial databases, Newsfile delivers press releases to a global audience.
- PDAC 2025 draws 27,353 participants to Toronto
- China's unwavering opening-up efforts unlock global opportunities
- Twin jewellery shows attract over 82,000 global buyers
- ROSEN, NATIONAL TRIAL LAWYERS, Encourages The Trade Desk, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TTD
- ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages TELUS International (Cda) Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TIXT
- ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Target Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGT
